ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells.
We report here for the first time the ESM-1 targeting in PC-3 cells, which resulted in decreased migration, which may be related, at least in part, to decreased expression of the angiogenic CXCL3 chemokine, whose expression was found to be reduced in ESM-1-siRNA transfected cells. Additional studies are required to ascertain the biological role of ESM-1 in prostate cancer cells and the link with the expression of CXCL3.
PMID: 28533735 [PubMed - in process]
Source: International Journal of Biomedical Science - Category: Biomedical Science Tags: Int J Biomed Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Genetics | Prostate Cancer | Science | Study